Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Empagliflozin on the Renin-angiotensin System in Patients With Chronic

NCT03078101 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03078101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03078101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Empagliflozin on the Renin-angiotensin System in Patients With Chronic
Lead sponsor
Medical University of Vienna
Phase
Phase 2
Overall status
Completed
Start date
April 15, 2017
Completion date
August 7, 2019
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage3, chronic kidney disease stage4, diabetes mellitus, type 2, diabetic kidney disease